DENTSPLY SIRONA Inc. (XRAY)
USD 12.66
(-4.38%)
USD 12.66
(-4.38%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 624 Million USD | -0.48% |
| 2022 | 627 Million USD | 24.4% |
| 2021 | 504 Million USD | 8.15% |
| 2020 | 466 Million USD | -17.04% |
| 2019 | 561.7 Million USD | -6.21% |
| 2018 | 598.9 Million USD | -3.88% |
| 2017 | 623.1 Million USD | 20.5% |
| 2016 | 517.1 Million USD | 51.91% |
| 2015 | 340.4 Million USD | -12.06% |
| 2014 | 387.09 Million USD | -11.73% |
| 2013 | 438.55 Million USD | 8.84% |
| 2012 | 402.94 Million USD | 11.38% |
| 2011 | 361.76 Million USD | 17.17% |
| 2010 | 308.73 Million USD | 5.86% |
| 2009 | 291.64 Million USD | -4.73% |
| 2008 | 306.12 Million USD | 18.64% |
| 2007 | 258.03 Million USD | 11.01% |
| 2006 | 232.44 Million USD | 11.65% |
| 2005 | 208.17 Million USD | -2.59% |
| 2004 | 213.7 Million USD | 3.95% |
| 2003 | 205.58 Million USD | -4.15% |
| 2002 | 214.49 Million USD | 8.63% |
| 2001 | 197.45 Million USD | 48.12% |
| 2000 | 133.3 Million USD | -1.62% |
| 1999 | 135.5 Million USD | -2.66% |
| 1998 | 139.2 Million USD | 11.63% |
| 1997 | 124.7 Million USD | -0.56% |
| 1996 | 125.4 Million USD | -0.24% |
| 1995 | 125.7 Million USD | 41.39% |
| 1994 | 88.9 Million USD | -4.92% |
| 1993 | 93.5 Million USD | 495.54% |
| 1992 | 15.7 Million USD | 0.64% |
| 1991 | 15.6 Million USD | 108.0% |
| 1990 | 7.5 Million USD | 59.57% |
| 1989 | 4.7 Million USD | -4.08% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 613 Million USD | -1.76% |
| 2024 Q2 | 608 Million USD | -0.82% |
| 2023 Q3 | 651 Million USD | -0.91% |
| 2023 Q4 | 624 Million USD | -4.15% |
| 2023 Q1 | 659 Million USD | 5.1% |
| 2023 Q2 | 657 Million USD | -0.3% |
| 2023 FY | 624 Million USD | -0.48% |
| 2022 Q4 | 627 Million USD | 5.91% |
| 2022 Q1 | 541 Million USD | 7.34% |
| 2022 Q3 | 592 Million USD | 1.89% |
| 2022 Q2 | 581 Million USD | 7.39% |
| 2022 FY | 627 Million USD | 24.4% |
| 2021 Q1 | 500 Million USD | 7.3% |
| 2021 Q4 | 504 Million USD | -5.26% |
| 2021 Q3 | 532 Million USD | -1.3% |
| 2021 FY | 504 Million USD | 8.15% |
| 2021 Q2 | 539 Million USD | 7.8% |
| 2020 Q2 | 548.9 Million USD | -7.04% |
| 2020 Q3 | 489.1 Million USD | -10.89% |
| 2020 Q4 | 466 Million USD | -4.72% |
| 2020 FY | 466 Million USD | -17.04% |
| 2020 Q1 | 590.5 Million USD | 5.13% |
| 2019 FY | 561.7 Million USD | -6.21% |
| 2019 Q4 | 561.7 Million USD | -7.17% |
| 2019 Q2 | 608.3 Million USD | -1.6% |
| 2019 Q3 | 605.1 Million USD | -0.53% |
| 2019 Q1 | 618.2 Million USD | 3.22% |
| 2018 Q3 | 672 Million USD | 0.86% |
| 2018 Q2 | 666.3 Million USD | -4.35% |
| 2018 Q1 | 696.6 Million USD | 11.8% |
| 2018 Q4 | 598.9 Million USD | -10.88% |
| 2018 FY | 598.9 Million USD | -3.88% |
| 2017 Q1 | 565.1 Million USD | 9.28% |
| 2017 FY | 623.1 Million USD | 20.5% |
| 2017 Q4 | 623.1 Million USD | -0.21% |
| 2017 Q3 | 624.4 Million USD | 4.62% |
| 2017 Q2 | 596.8 Million USD | 5.61% |
| 2016 Q4 | 517.1 Million USD | -7.06% |
| 2016 Q3 | 556.4 Million USD | 6.37% |
| 2016 Q1 | 562.1 Million USD | 65.13% |
| 2016 FY | 517.1 Million USD | 51.91% |
| 2016 Q2 | 523.1 Million USD | -6.94% |
| 2015 Q2 | 374.82 Million USD | -1.39% |
| 2015 Q1 | 380.09 Million USD | -1.81% |
| 2015 FY | 340.4 Million USD | -12.06% |
| 2015 Q4 | 340.4 Million USD | -5.78% |
| 2015 Q3 | 361.3 Million USD | -3.61% |
| 2014 Q1 | 455.07 Million USD | 3.77% |
| 2014 Q3 | 422.48 Million USD | -8.4% |
| 2014 FY | 387.09 Million USD | -11.73% |
| 2014 Q4 | 387.09 Million USD | -8.38% |
| 2014 Q2 | 461.2 Million USD | 1.35% |
| 2013 Q4 | 438.55 Million USD | -2.17% |
| 2013 Q1 | 417.09 Million USD | 3.51% |
| 2013 Q2 | 433.18 Million USD | 3.86% |
| 2013 Q3 | 448.27 Million USD | 3.48% |
| 2013 FY | 438.55 Million USD | 8.84% |
| 2012 FY | 402.94 Million USD | 11.38% |
| 2012 Q1 | 403.05 Million USD | 11.41% |
| 2012 Q2 | 403.19 Million USD | 0.04% |
| 2012 Q3 | 415.92 Million USD | 3.16% |
| 2012 Q4 | 402.94 Million USD | -3.12% |
| 2011 FY | 361.76 Million USD | 17.17% |
| 2011 Q4 | 361.76 Million USD | -7.6% |
| 2011 Q3 | 391.52 Million USD | 16.11% |
| 2011 Q2 | 337.2 Million USD | 1.48% |
| 2011 Q1 | 332.28 Million USD | 7.63% |
| 2010 Q3 | 318.07 Million USD | 11.84% |
| 2010 Q2 | 284.39 Million USD | -5.58% |
| 2010 FY | 308.73 Million USD | 5.86% |
| 2010 Q4 | 308.73 Million USD | -2.93% |
| 2010 Q1 | 301.19 Million USD | 3.28% |
| 2009 Q1 | 314.08 Million USD | 2.6% |
| 2009 Q3 | 311.66 Million USD | 0.72% |
| 2009 Q4 | 291.64 Million USD | -6.43% |
| 2009 FY | 291.64 Million USD | -4.73% |
| 2009 Q2 | 309.43 Million USD | -1.48% |
| 2008 Q2 | 282.79 Million USD | 0.66% |
| 2008 Q3 | 278.76 Million USD | -1.43% |
| 2008 Q4 | 306.12 Million USD | 9.82% |
| 2008 FY | 306.12 Million USD | 18.64% |
| 2008 Q1 | 280.93 Million USD | 8.87% |
| 2007 FY | 258.03 Million USD | 11.01% |
| 2007 Q1 | 247.51 Million USD | 6.49% |
| 2007 Q2 | 249.86 Million USD | 0.95% |
| 2007 Q4 | 258.03 Million USD | -6.87% |
| 2007 Q3 | 277.05 Million USD | 10.88% |
| 2006 Q1 | 226.44 Million USD | 8.77% |
| 2006 Q2 | 229.37 Million USD | 1.29% |
| 2006 Q3 | 236.27 Million USD | 3.01% |
| 2006 Q4 | 232.44 Million USD | -1.62% |
| 2006 FY | 232.44 Million USD | 11.65% |
| 2005 Q1 | 224.09 Million USD | 4.86% |
| 2005 FY | 208.17 Million USD | -2.59% |
| 2005 Q3 | 228.96 Million USD | 2.11% |
| 2005 Q4 | 208.17 Million USD | -9.08% |
| 2005 Q2 | 224.22 Million USD | 0.06% |
| 2004 FY | 213.7 Million USD | 3.95% |
| 2004 Q1 | 207.83 Million USD | 1.09% |
| 2004 Q2 | 203.17 Million USD | -2.24% |
| 2004 Q3 | 212.05 Million USD | 4.37% |
| 2004 Q4 | 213.7 Million USD | 0.78% |
| 2003 FY | 205.58 Million USD | -4.15% |
| 2003 Q4 | 205.58 Million USD | -10.64% |
| 2003 Q3 | 230.05 Million USD | 0.2% |
| 2003 Q2 | 229.59 Million USD | 0.3% |
| 2003 Q1 | 228.9 Million USD | 6.72% |
| 2002 Q2 | 222.91 Million USD | 9.18% |
| 2002 FY | 214.49 Million USD | 8.63% |
| 2002 Q1 | 204.17 Million USD | 3.4% |
| 2002 Q4 | 214.49 Million USD | -2.41% |
| 2002 Q3 | 219.78 Million USD | -1.4% |
| 2001 Q3 | 163.85 Million USD | 5.94% |
| 2001 Q1 | 143 Million USD | 7.28% |
| 2001 FY | 197.45 Million USD | 48.12% |
| 2001 Q2 | 154.67 Million USD | 8.16% |
| 2001 Q4 | 197.45 Million USD | 20.51% |
| 2000 Q4 | 133.3 Million USD | -3.72% |
| 2000 Q2 | 139.21 Million USD | 1.99% |
| 2000 Q1 | 136.49 Million USD | 0.74% |
| 2000 FY | 133.3 Million USD | -1.62% |
| 2000 Q3 | 138.45 Million USD | -0.54% |
| 1999 FY | 135.5 Million USD | -2.66% |
| 1999 Q3 | 141.7 Million USD | 3.13% |
| 1999 Q4 | 135.5 Million USD | -4.38% |
| 1999 Q1 | 140.6 Million USD | 1.01% |
| 1999 Q2 | 137.4 Million USD | -2.28% |
| 1998 Q2 | 152.6 Million USD | 16.85% |
| 1998 Q4 | 139.2 Million USD | -12.84% |
| 1998 Q3 | 159.7 Million USD | 4.65% |
| 1998 Q1 | 130.6 Million USD | 4.73% |
| 1998 FY | 139.2 Million USD | 11.63% |
| 1997 FY | 124.7 Million USD | -0.56% |
| 1997 Q1 | 129.7 Million USD | 3.43% |
| 1997 Q2 | 117.6 Million USD | -9.33% |
| 1997 Q3 | 121.6 Million USD | 3.4% |
| 1997 Q4 | 124.7 Million USD | 2.55% |
| 1996 Q1 | 129.3 Million USD | 2.86% |
| 1996 FY | 125.4 Million USD | -0.24% |
| 1996 Q2 | 128.6 Million USD | -0.54% |
| 1996 Q3 | 131.8 Million USD | 2.49% |
| 1996 Q4 | 125.4 Million USD | -4.86% |
| 1995 Q3 | 129.6 Million USD | -1.89% |
| 1995 Q2 | 132.1 Million USD | 36.05% |
| 1995 FY | 125.7 Million USD | 41.39% |
| 1995 Q4 | 125.7 Million USD | -3.01% |
| 1995 Q1 | 97.1 Million USD | 9.22% |
| 1994 FY | 88.9 Million USD | -4.92% |
| 1994 Q1 | 100.6 Million USD | 7.59% |
| 1994 Q2 | 105.7 Million USD | 5.07% |
| 1994 Q3 | 91.9 Million USD | -13.06% |
| 1994 Q4 | 88.9 Million USD | -3.26% |
| 1993 Q3 | 101.6 Million USD | 1.91% |
| 1993 FY | 93.5 Million USD | 495.54% |
| 1993 Q1 | 33.1 Million USD | 0.0% |
| 1993 Q2 | 99.7 Million USD | 201.21% |
| 1993 Q4 | 93.5 Million USD | -7.97% |
| 1992 Q2 | 20 Million USD | 27.39% |
| 1992 Q3 | 31.8 Million USD | 59.0% |
| 1992 Q1 | 15.7 Million USD | 4.67% |
| 1992 FY | 15.7 Million USD | 0.64% |
| 1992 Q4 | 33.1 Million USD | 4.09% |
| 1991 Q2 | 15.5 Million USD | -0.64% |
| 1991 FY | 15.6 Million USD | 108.0% |
| 1991 Q3 | 14.9 Million USD | -3.87% |
| 1991 Q4 | 15 Million USD | 0.67% |
| 1991 Q1 | 15.6 Million USD | -6.59% |
| 1990 Q1 | 7.5 Million USD | -5.06% |
| 1990 FY | 7.5 Million USD | 59.57% |
| 1990 Q2 | 8.1 Million USD | 8.0% |
| 1990 Q3 | 18.1 Million USD | 123.46% |
| 1990 Q4 | 16.7 Million USD | -7.73% |
| 1989 Q1 | 4.7 Million USD | 0.0% |
| 1989 FY | 4.7 Million USD | -4.08% |
| 1989 Q3 | 7.4 Million USD | 0.0% |
| 1989 Q2 | 7.4 Million USD | 57.45% |
| 1989 Q4 | 7.9 Million USD | 6.76% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 17.87 Million USD | -3390.519% |
| AngioDynamics, Inc. | 60.61 Million USD | -929.431% |
| AtriCure, Inc. | 67.89 Million USD | -819.039% |
| Avinger, Inc. | 5.29 Million USD | -11678.029% |
| Azenta, Inc. | 128.19 Million USD | -386.747% |
| BioLife Solutions, Inc. | 43.45 Million USD | -1335.935% |
| The Cooper Companies, Inc. | 735.6 Million USD | 15.171% |
| Daxor Corporation | - USD | -Infinity% |
| Ekso Bionics Holdings, Inc. | 5.05 Million USD | -12256.436% |
| Femasys Inc. | 667.11 Thousand USD | -93436.676% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 24.71 Million USD | -2424.68% |
| Hologic, Inc. | 679.8 Million USD | 8.208% |
| ICU Medical, Inc. | 709.36 Million USD | 12.033% |
| Intuitive Surgical, Inc. | 1.22 Billion USD | 48.878% |
| KORU Medical Systems, Inc. | 3.48 Million USD | -17824.333% |
| LeMaitre Vascular, Inc. | 52.33 Million USD | -1092.364% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -72732.617% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -72732.617% |
| Masimo Corporation | 545 Million USD | -14.495% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 1.61 Million USD | -38484.613% |
| Merit Medical Systems, Inc. | 303.87 Million USD | -105.35% |
| Nephros, Inc. | 2.47 Million USD | -25163.158% |
| NovoCure Limited | 38.15 Million USD | -1535.563% |
| NEXGEL, Inc. | 1.31 Million USD | -47208.567% |
| NEXGEL, Inc. | 1.31 Million USD | -47208.567% |
| Singular Genomics Systems, Inc. | 13.57 Million USD | -4497.701% |
| OraSure Technologies, Inc. | 47.61 Million USD | -1210.539% |
| Pro-Dex, Inc. | 15.26 Million USD | -3986.712% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 494.37 Thousand USD | -126120.23% |
| Precision Optics Corporation, Inc. | 2.86 Million USD | -21656.564% |
| QuidelOrtho Corporation | 577.8 Million USD | -7.996% |
| Repligen Corporation | 202.32 Million USD | -208.421% |
| Sanara MedTech Inc. | 4.71 Million USD | -13127.252% |
| STAAR Surgical Company | 35.13 Million USD | -1676.26% |
| Sharps Technology, Inc. | 1.7 Million USD | -36409.696% |
| Utah Medical Products, Inc. | 9.58 Million USD | -6412.21% |
| Jin Medical International Ltd. | 5.05 Million USD | -12248.767% |